Loading clinical trials...
Loading clinical trials...
Evaluate anti-cancer activity (e.g. proportion of patients with confirmed complete response or partial response) in patients with advanced, inoperable biopsy-proven hepatocellular carcinoma.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bayer
NCT06687941 · Neoplasms, Carcinoma, Hepatocellular, and more
NCT07010497 · Carcinoma, Hepatocellular
NCT06571396 · Carcinoma, Hepatocellular, Immunotherapy
NCT06454578 · Carcinoma, Hepatocellular
NCT05870969 · Carcinoma, Hepatocellular, Hepatitis C, Chronic, and more
Los Angeles, California
New York, New York
Bruxelles - Brussel
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions